Australia TGA ARTG recordOpen-surgery electrosurgical forceps, single-use
Australia TGA ARTG Registered Device · Erbe Australia Pty Ltd · Erbe Elektromedizin GmbH · Class IIb · Started November 20, 2023
Good Name: Erbe Australia Pty Ltd - Open-surgery electrosurgical forceps, single-use
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- November 20, 2023
- Effective Date
- November 20, 2023
- Country
- Germany
- Address
- Waldhornlestrasse 17, Tubingen, Tubingen, 72072
The TriSect rapide is intended for bipolar coagulation, division and sealing of vessels and tissue bundles as well as to grasp, dissect and cut tissue. It is also intended to be used for soft tissue incisions when bleeding control and minimal thermal injury are desired. The TriSect rapide is indicated for use in open, minimal invasive and endoscopic assisted procedures including but not limited to: • gynecological, urologic, pediatric, plastic, ENT, general and thoracic interventions • interventions such as hysterectomies, adhesiolysis, oophorectomies, Nissen fundoplication, bowel resections, and gall bladder procedures • sealing of vessels such as arteries, veins, pulmonary vasculature and lymphatics up to and including diameters of 5 mm and tissue bundles
Access comprehensive regulatory information for Open-surgery electrosurgical forceps, single-use in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Erbe Australia Pty Ltd, manufactured by Erbe Elektromedizin GmbH in Germany. The device registration started on November 20, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.